Lower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: data from an international inception cohort

Date
2021
Author
Hanly, John G.
Fortin, Paul R.
Bae, Sang-Cheol
Gordon, Caroline
Clarke, Ann E.
Bernatsky, Sasha
Isenberg, David
Rahman, Anisur
Sanchez-Guerrero, Jorge
Romero-Diaz, Juanita
Merrill, Joan
Wallace, Daniel
Ginzler, Ellen
Khamashta, Munther
Nived, Ola
Jonsen, Andreas
Steinsson, Kristjan
Manzi, Susan
Kalunian, Ken
Dooley, Mary Anne
Petri, Michelle
Aranow, Cynthia
van Vollenhoven, Ronald
Stoll, Thomas
Alarcon, Graciela S.
Lim, S. Sam
Ruiz-Irastorza, Guillermo
Peschken, Christine A.
Askanase, Anca D.
Kamen, Diane L.
Inanc, Murat
Ramsey-Goldman, Rosalind
Bruce, Ian N.
Chew, Christine
Reynolds, John A.
Lertratanakul, Apinya
Wu, Peggy
Urowitz, Murray
Gladman, Dafna D.
Metadata
Show full item record
Abstract
Objectives. Vitamin D (25(OH)D) deficiency and metabolic syndrome (MetS) may both contribute to increased cardiovascular risk in SLE. We aimed to examine the association of demographic factors, SLE phenotype, therapy and vitamin D levels with MetS and insulin resistance.
URI
http://hdl.handle.net/20.500.12627/169000
https://doi.org/10.1093/rheumatology/keab090
Collections